Does gender have an influence on platelet function and the efficacy of oral antiplatelet therapy?

Published

Journal Article (Review)

The underlying pathophysiology of ischemic complications during acute coronary syndrome involves thrombus generation at sites of plaque rupture and endothelial erosion, in which platelet activation and aggregation play major roles. This review discusses whether there are intrinsic differences in thrombogenicity between genders. In trials of acute coronary syndromes with dual antiplatelet therapy strategies, women tend to experience more ischemic events. Controversy exists surrounding the protective role of estrogens in the premenopausal woman. In vitro studies support the attenuation of platelet function by estrogen. Sufficient data support the presence of gender differences in thrombogenicity to promote further investigation in this area. © 2012 Elsevier Inc.

Full Text

Duke Authors

Cited Authors

  • Tantry, US; Navarese, EP; Gurbel, PA

Published Date

  • April 1, 2012

Published In

Volume / Issue

  • 1 / 2

Start / End Page

  • 223 - 230

International Standard Serial Number (ISSN)

  • 2211-7458

Digital Object Identifier (DOI)

  • 10.1016/j.iccl.2012.01.007

Citation Source

  • Scopus